Cancer Research Infection and Cancer: Biology, Therapeutics, and Prevention
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 26, 1661-1664, August 1, 1966]
© 1966 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kim, J. H.
Right arrow Articles by Fox, J. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kim, J. H.
Right arrow Articles by Fox, J. J.

Action of 1-ß-D-Arabinofuranosyl-5-fluorocytosine on the Nucleic Acid Metabolism and Viability of HeLa Cells1

Jae Ho Kim, Maxwell L. Eidinoff and Jack J. Fox

Divisions of Biophysics and Biological Chemistry, Sloan-Kettering Institute for Cancer Research, New York, New York

Exposure of HeLa S-3 cells to 4 x 10-6 M 1-ß-D-arabinofuranosyl-5-fluorocytosine (ara-FC)2 arrested cell division. In the 1st 24-hr period, RNA and protein increased by a factor of about 2 while there was only a slight increase in the amount of DNA. The cell viability (defined as the capacity of a cell to grow out into a macroscopic clone) declined sharply following exposure to 1 x 10-6 M ara-FC for more than 1 generation time. These results strongly suggest a state of unbalanced growth similar to that previously observed with 5-fluorodeoxyuridine, excess thymidine and 1-ß-D-arabinofuranosylcytosine (ara-C). The inhibition by ara-FC could be effectively prevented by simultaneous exposure of cells to a 100-fold excess of deoxycytidine, but not cytidine, thymidine, or deoxyuridine.

These results, strikingly similar to those previously obtained with are-C, demonstrate that replacement of a hydrogen atom at the 5-position of the cytosine moiety of ara-C by the considerably more electronegative fluorine atom does not appreciably alter several important biochemical sites of inhibitory activity.

1 This work was aided by grants from the National Cancer Institute (C-3811), and the Atomic Energy Commission (AT (30-1)-910).

Received 1/17/66.





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1966 by the American Association for Cancer Research.